Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

2011536 citationsJournal Articlehybrid Open Access

Authors

T. Hugh Jones

Stefan Arver · Karolinska University Hospital

Hermann M. Behre · Martin Luther University Halle-Wittenberg

Irène Buvat · Center for Infection and Immunity of Lille

E.J.H. Meuleman · Amsterdam UMC Location VUmc

Ignacio Moncada · Hospital La Luz

Antonio Martín Morales

Maurizio Volterrani

Abstract

Over a 6-month period, transdermal TRT was associated with beneficial effects on insulin resistance, total and LDL-cholesterol, Lpa, and sexual health in hypogonadal men with type 2 diabetes and/or MetS.

Topics & Keywords

Hormonal and reproductive studies Pharmacology and Obesity Treatment Hypothalamic control of reproductive hormones

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 34, Issue 4, pp. 828-837

DOI: 10.2337/dc10-1233

Field-Weighted Citation Impact: 34.23